Feb 13, 2025 8:00 am EST Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business Update
Feb 10, 2025 8:05 am EST Grace Therapeutics Announces Private Placement Financing of up to $30 Million
Feb 10, 2025 8:01 am EST Grace Therapeutics Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH
Dec 4, 2024 8:00 am EST Grace Therapeutics to Exhibit at the American Society of Health-System Pharmacists Conference
Nov 13, 2024 8:00 am EST Grace Therapeutics Announces Second Fiscal Quarter 2025 Financial Results, Provides Business Update
Oct 30, 2024 8:00 am EDT Grace Therapeutics to Host Virtual KOL Event on GTx-104 in aneurysmal Subarachnoid Hemorrhage on November 20, 2024
Sep 25, 2024 7:30 am EDT Acasti Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104